The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-ethyl-2-[(6'-fluoro-2'-oxo-spiro[cyclopropane-1,3'-indoline]-1'-yl)methyl]-1-(4,4,4-trifluorobutyl)benzimidazole-5-carboxamidine ID: ALA4869353
PubChem CID: 164622372
Max Phase: Preclinical
Molecular Formula: C25H25F4N5O
Molecular Weight: 487.50
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCNC(=N)c1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F
Standard InChI: InChI=1S/C25H25F4N5O/c1-2-31-22(30)15-4-7-19-18(12-15)32-21(33(19)11-3-8-25(27,28)29)14-34-20-13-16(26)5-6-17(20)24(9-10-24)23(34)35/h4-7,12-13H,2-3,8-11,14H2,1H3,(H2,30,31)
Standard InChI Key: JHYCMKIVZSOJDH-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
9.8916 -4.4708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3083 -5.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7206 -4.4683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8247 -8.0194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5411 -7.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5382 -6.7755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8229 -6.3663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1098 -7.6065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1065 -6.7822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3216 -6.5306 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8396 -7.1994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3269 -7.8643 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0146 -7.2028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5993 -6.4900 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9276 -5.7374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7744 -6.4095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6016 -5.6038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8190 -5.3521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2085 -5.9051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3857 -6.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1681 -6.9610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7333 -5.5600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7765 -7.2693 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.0751 -8.6499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6297 -9.2608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3779 -10.0464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9324 -10.6572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6807 -11.4429 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.7387 -10.4825 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.5124 -11.2374 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.2512 -6.3603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9671 -6.7700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2480 -5.5353 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6801 -6.3549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3961 -6.7647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
1 3 1 0
8 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 9 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
11 13 1 0
13 14 1 0
14 15 1 0
15 2 1 0
2 17 1 0
16 14 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
15 22 2 0
20 23 1 0
12 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
27 29 1 0
27 30 1 0
6 31 1 0
31 32 1 0
31 33 2 0
32 34 1 0
34 35 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 487.50Molecular Weight (Monoisotopic): 487.1995AlogP: 5.03#Rotatable Bonds: 7Polar Surface Area: 74.01Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 10.75CX LogP: 4.09CX LogD: 1.72Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.28Np Likeness Score: -1.24
References 1. Cockerill GS, Angell RM, Bedernjak A, Chuckowree I, Fraser I, Gascon-Simorte J, Gilman MSA, Good JAD, Harland R, Johnson SM, Ludes-Meyers JH, Littler E, Lumley J, Lunn G, Mathews N, McLellan JS, Paradowski M, Peeples ME, Scott C, Tait D, Taylor G, Thom M, Thomas E, Villalonga Barber C, Ward SE, Watterson D, Williams G, Young P, Powell K.. (2021) Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion., 64 (7.0): [PMID:33729773 ] [10.1021/acs.jmedchem.0c01882 ]